Introduction

GLP-1 weight-loss injections are clinically approved treatments used to support weight loss in people who struggle to lose weight through lifestyle changes alone. Medications such as Wegovy (semaglutide) and Mounjaro (tirzepatide) work by regulating appetite, slowing digestion, and improving blood-sugar control, which helps reduce calorie intake and support long-term weight loss when combined with diet and physical activity [1][2].

As with all prescription medicines, weight-loss injections can cause side effects. Most side effects are mild to moderate, occur early in treatment, and improve as the body adapts to the medication [3]. Understanding potential side effects helps patients know what to expect and when to seek medical advice.

For a broader overview of how GLP-1 weight-loss injections work, who they are suitable for, and what to expect from treatment overall, see our GLP-1 weight loss injections complete guide.


What Side Effects Can Weight Loss Injections Cause?

The majority of side effects associated with GLP-1 weight-loss injections affect the digestive system. This is due to how these medications slow gastric emptying and act on appetite-regulating hormones in the brain [3][4].

Side effects are most commonly reported:

  • When starting treatment

  • During dose increases

  • If meals are large, high in fat, or eaten quickly


Common Side Effects

The most frequently reported side effects include:

  • Nausea

  • Vomiting

  • Diarrhoea

  • Constipation

  • Abdominal discomfort or bloating

  • Reduced appetite

  • Feeling full sooner than usual

Clinical trial data for both semaglutide and tirzepatide shows gastrointestinal side effects are most noticeable in the early weeks of treatment and typically reduce over time as patients reach a maintenance dose [1][2][3].


Less Common Side Effects

Some people may experience additional side effects, although these are reported less frequently:

  • Headache

  • Fatigue or low energy

  • Dizziness

  • Acid reflux or indigestion

  • Injection-site reactions such as redness, itching, or mild swelling

Injection-site reactions are usually mild and resolve without treatment [1][2].


Rare but Serious Side Effects

Serious side effects are uncommon, but it is important to be aware of them.

Seek urgent medical advice if you experience:

  • Severe or persistent abdominal pain

  • Symptoms of pancreatitis, such as severe upper abdominal pain that may radiate to the back

  • Signs of gallbladder disease, including right-sided abdominal pain or jaundice

  • Persistent vomiting that may lead to dehydration

GLP-1 medications are not suitable for everyone, and a full medical assessment is required before starting treatment [5].


Why Do Side Effects Occur?

GLP-1 receptor agonists mimic a naturally occurring hormone that:

  • Slows digestion

  • Reduces hunger signals

  • Enhances feelings of fullness

These effects support weight loss but can temporarily disrupt normal digestive processes, particularly during dose escalation. This is why doses are increased gradually to improve tolerability [3][4].


How to Reduce Side Effects

Many side effects can be reduced with simple changes:

  • Eat smaller, more frequent meals

  • Avoid high-fat or greasy foods

  • Eat slowly and mindfully

  • Stay well hydrated

  • Avoid lying down immediately after eating

  • Follow the prescribed dosing schedule

Most patients find side effects improve significantly once they reach a stable dose [3].

Food choices can have a significant impact on how well side effects are tolerated. Our guide on what to eat while using weight loss injections explains which foods are easier to digest and how diet can help minimise nausea and other digestive symptoms during treatment.


When to Speak to a Clinician

You should speak to a healthcare professional if:

  • Side effects interfere with daily life

  • Symptoms worsen rather than improve

  • You experience severe abdominal pain or ongoing vomiting

Ongoing clinical monitoring helps ensure treatment remains safe and effective [5].

Start Your GLP-1 Treatment Safely

Complete our quick and secure online consultation. Our pharmacy team will review your answers and advise on the most suitable GLP-1 weight-loss treatment for you.

Start Your Weight Loss Consultation

FAQs

Do weight loss injections cause side effects?
Yes. Like all prescription medicines, weight loss injections can cause side effects. Most are mild to moderate and occur early in treatment, particularly when starting or increasing the dose.
What are the most common side effects of weight loss injections?
The most common side effects are gastrointestinal and include nausea, vomiting, diarrhoea, constipation, bloating, and reduced appetite. These usually improve as the body adjusts.
How long do side effects from GLP-1 injections last?
Side effects are usually temporary and tend to improve within a few weeks. Many people notice fewer symptoms once they reach a stable maintenance dose.
Are side effects worse when starting treatment?
Yes. Side effects are most commonly reported when treatment first begins or after a dose increase. This is why doses are increased gradually.
Do side effects mean the injections are unsafe?
No. Mild side effects are a known and expected part of how these medications work. Serious side effects are rare, but you should speak to a clinician if symptoms are severe or persistent.
Can weight loss injection side effects be reduced?
Yes. Eating smaller meals, avoiding high-fat foods, eating slowly, staying hydrated, and following the prescribed dosing schedule can help reduce side effects.
Are injection site reactions common?
Injection site reactions such as redness, itching, or mild swelling can occur, but they are usually mild and resolve on their own without treatment.
What serious side effects should I watch out for?
You should seek medical advice if you experience severe abdominal pain, persistent vomiting, signs of pancreatitis, or symptoms of gallbladder problems such as right-sided abdominal pain or jaundice.
Can everyone use weight loss injections safely?
No. Weight loss injections are not suitable for everyone. A full medical assessment is required to ensure treatment is appropriate based on your health history and current medications.
When should I contact a healthcare professional?
You should contact a healthcare professional if side effects interfere with daily life, worsen over time, or do not improve after the initial weeks of treatment.

References

1. Wegovy (Semaglutide) – Clinical & Safety Evidence

• STEP-1 Trial: Once-weekly semaglutide in adults with overweight or obesity – NEJM
• STEP-1 Clinical Trial Registration – ClinicalTrials.gov
• Semaglutide for weight management (STEP-1 primary publication) – PubMed

2. Mounjaro (Tirzepatide) – Clinical & Safety Evidence

• SURMOUNT-1 Trial: Tirzepatide once weekly for the treatment of obesity – NEJM
• SURMOUNT-1 Clinical Trial Registration – ClinicalTrials.gov
• SURMOUNT-1 weight-loss and safety outcomes – PubMed

3. GLP-1 Receptor Agonists – Gastrointestinal Tolerability

• Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity – Diabetes, Obesity and Metabolism (PubMed)
• Gastrointestinal safety of semaglutide and tirzepatide vs placebo in obese individuals without diabetes – Systematic review & meta-analysis (PubMed)

4. Clinical Guidance on GLP-1 Weight-Loss Treatment

• Medicines for obesity: overview of GLP-1 weight-loss injections and common side effects – NHS England
• Semaglutide for managing overweight and obesity (technology appraisal) – NICE TA875

5. Safety & Regulatory Information

• GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse – MHRA Drug Safety Update
• Overweight and obesity: identification, assessment and management – NICE NG246

Medically Reviewed by Our GPhC-Registered Pharmacists

GPhC Logo National Pharmacy Association Logo
Palvinder Deol

Authored by:

Palvinder Deol
Superintendent Pharmacist
Over 25 years’ clinical experience.
GPhC: 2047066
Nigel Howard

Reviewed by:

Nigel Howard
Independent Prescriber
Over 20 years’ clinical experience.
GPhC: 2047450

This article was medically reviewed for accuracy, safety, and alignment with UK clinical standards. Learn about our medical review process →

Content last updated: 17th December 2025 · Next review: January 2026

GPhC Inspection Result

General Pharmaceutical Council Logo

Inspection Outcome: All Standards Met

Our digital-first pharmacy achieved rare “Good Practice” recognition during our GPhC inspection on 19 May 2025 — showcasing our commitment to safe, high-quality and innovative online healthcare.

View full inspection report →

GPhC Registration No. 9012585 | Inspected 19 May 2025